These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 5868675)

  • 21. Human factor XIII: fibrin-stabilizing factor.
    Lorand L; Losowsky MS; Miloszewski KJ
    Prog Hemost Thromb; 1980; 5():245-90. PubMed ID: 7422874
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hemorrhagic disease due to a defect of the fibrin stabilizing factor].
    Ottaviani P; Mandelli F; Fontana L; Morelli R
    Recenti Prog Med; 1966 May; 40(5):377-407. PubMed ID: 6012638
    [No Abstract]   [Full Text] [Related]  

  • 23. Estimation of plasma fibrin-stabilizing factor in families showing congenital deficiencies.
    Losowsky MS; Hall R
    Clin Sci; 1966 Feb; 30(1):171-8. PubMed ID: 5910931
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitative estimation of fibrin stabilizing factor, alterations of its activity by fibrinolysis.
    Heene DL
    Thromb Diath Haemorrh; 1968 Jul; 19(3):600-1. PubMed ID: 5708137
    [No Abstract]   [Full Text] [Related]  

  • 25. Reduction of fibrin stabilizing factor (FSF) in thrombocytopenia in childhood.
    Ströder J
    Ann Paediatr; 1965; 205(6):438-41. PubMed ID: 5898747
    [No Abstract]   [Full Text] [Related]  

  • 26. [The significance of changes in the functional properties of blood platelets, factor XIII activity and fibrin clot quality in the pathogenesis of hemorrhagic diathesis secondary to experimental vitamin C deficiency].
    Sushkevich GN; Khnychev SS; Oĭvin VI
    Vopr Pitan; 1969; 28(5):23-7. PubMed ID: 5370913
    [No Abstract]   [Full Text] [Related]  

  • 27. [CONGENITAL BLOOD COAGULATION DISORDER ASSOCIATED WITH A DEFICIENCY OF FIBRIN-STABILIZING FACTOR (FSF)].
    MASURE R
    Hemostase; 1963; 3():119-22. PubMed ID: 14050809
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the evaluation of factor 13 (fibrin stabilizing factor) by means of the MIA-tolerance (visual and thrombelastographic technique).
    de Nicola P; Spreafico PL
    Hemostase; 1966; 6(5):325-32. PubMed ID: 5999891
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hemorrhagic syndrome conditioned by congenital deficiency of factor XIII. On the occasion of the first case discovered in Yugoslavia].
    Rolović Z; Berović R
    Srp Arh Celok Lek; 1968 Jun; 96(6):593-602. PubMed ID: 5192188
    [No Abstract]   [Full Text] [Related]  

  • 30. Congenital deficiency of factor 13 (fibrin-stabilizing factor): Report of a case and review of the literature.
    Britten AF
    Am J Med; 1967 Nov; 43(5):751-61. PubMed ID: 6054840
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma fibrin-stabilizing factor activity in acquired disease.
    Walls WD; Losowsky MS
    Br J Haematol; 1968 Sep; 15(3):327. PubMed ID: 5681498
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ontogenetic variability of fibrin stabilizing factor level (FSF--Factor XIII of blood coagulation system) in the plasma of healthy children].
    Zuch A; Rudobielska M; Zwierzowa W; Jurgielewicz E; Buluk K
    Pediatr Pol; 1972 Oct; 47(10):1197-203. PubMed ID: 5085405
    [No Abstract]   [Full Text] [Related]  

  • 33. [Afibrinogenemia and dysfibrinogenemia].
    Fukui H
    Nihon Rinsho; 1970 Aug; 28(8):2086-91. PubMed ID: 4917925
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in maternal coagulation factors after intra-amniotic injection of hypertonic saline.
    Stander RW; Flessa HC; Glueck HI; Kisker CT
    Obstet Gynecol; 1971 May; 37(5):660-6. PubMed ID: 5104670
    [No Abstract]   [Full Text] [Related]  

  • 35. [Congenital deficiency of fibrin stabilizing factor (factor XIII)].
    Barbui T; Di Luzio V
    G Clin Med; 1968 Jun; 49(6):646-61. PubMed ID: 4907419
    [No Abstract]   [Full Text] [Related]  

  • 36. [Activity of fibrin stabilizing factor (FSF; factor XIII) in lymphoproliferative disorders].
    Kłoczko J; Zuch A; Bielawiec M; Buluk K
    Acta Haematol Pol; 1983; 14(1):13-9. PubMed ID: 6577768
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical laboratory characteristics of the severe form of hereditary fibrin-stabilizing factor (factor XIII) deficiency].
    Barkagan LZ; Arkhipov BF
    Probl Gematol Pereliv Krovi; 1980 Aug; 25(8):54-8. PubMed ID: 7413627
    [No Abstract]   [Full Text] [Related]  

  • 38. [A case of congenital deficiency of factor XIII (FSF)].
    Lopaciuk S; Kozlowska J; Uszyński L
    Pol Arch Med Wewn; 1969 Feb; 42(2):255-9. PubMed ID: 5767982
    [No Abstract]   [Full Text] [Related]  

  • 39. Congenital factor XIII deficiency. Report of 2 cases.
    Fradera J; Haddock J; Pérez-Santiago E; Maldonado N
    Bol Asoc Med P R; 1969 Aug; 61(8):294-9. PubMed ID: 5271545
    [No Abstract]   [Full Text] [Related]  

  • 40. An acquired inhibitor to factor XIII.
    McDevitt NB; McDonagh J; Taylor HL; Roberts HR
    Arch Intern Med; 1972 Nov; 130(5):772-7. PubMed ID: 5083419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.